STEM Times Arkansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Arkansas.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 6, 2026

Mar. 6, 2026

Odysight.ai Partners with XP Services for First US Flight Testing of its AI-Predictive Maintenance System on UH-60 Helicopter

GlobeNewswire

Mar. 6, 2026

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

GlobeNewswire

Mar. 6, 2026

Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

GlobeNewswire

Mar. 6, 2026

C.M. Advises VisionWave of Joint Venture Initiative in India with Major Industrial Manufacturing Group

GlobeNewswire

Mar. 6, 2026

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights

GlobeNewswire

Mar. 6, 2026

Artelo Biosciences Announces Reverse Stock Split

GlobeNewswire

Mar. 6, 2026

Signing Day Sports Special Stockholder Meeting to Consider and Vote on Proposed Business Combination with BlockchAIn Digital Infrastructure to Be Held March 13, 2026

GlobeNewswire

Mar. 6, 2026

EagleNXT Announces Strategic Investment in Leading Israeli Precision Loitering Munition Innovator

GlobeNewswire

Mar. 6, 2026

Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

GlobeNewswire

Mar. 6, 2026

TSplus Releases Advanced Security v7.5 with Updated Ransomware Protection Driver

GlobeNewswire

Mar. 6, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire

Mar. 6, 2026

Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 6, 2026

Verano to Report Fourth Quarter and 2025 Full Year Financial Results on March 12th, 2026

GlobeNewswire

Mar. 6, 2026

AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update

GlobeNewswire

Mar. 6, 2026

Nano Labs Launches iPollo ClawPC A1 Mini, a Dedicated Hardware Solution for the OpenClaw AI Agent Ecosystem

GlobeNewswire

Mar. 6, 2026

Tangram Therapeutics gibt Dosierung des ersten Studienteilnehmers in der Phase-I/II-Studie RESTORE-MASH zu TGM-312 bekannt, einem in der Entwicklungsphase befindlichen RNAi-Therapeutikum

GlobeNewswire

Mar. 6, 2026

Tangram Therapeutics annonce l’administration de la première dose à un participant dans le cadre de l’essai RESTORE-MASH de phase I/II portant sur le TGM-312, un nouveau médicament expérimental à base d’ARNi

GlobeNewswire